M. M. Gruza et al. / Tetrahedron: Asymmetry 16 (2005) 1939–1946
1945
residue was chromatographed on a silica gel column
using 0.5–3% mixtures of methanol in chloroform.
108.9; 80.1; 75.0; 74.6; 71.9; 70.8; 66.9; 39.0; 26.7; 25.3;
MS (HR EI) m/z calcd for C27H42O10N3 [M+H]+:
568.2870. Found: 568.2845; EA (%) calcd: C, 57.1; H,
7.3; N, 7.4. Found: C, 56.9; H, 7.0; N, 7.3.
4.8.2. Method B (in the presence of MeOꢀ). Sodium
(1 equiv) was added to a cooled (5 ꢁC) solution
(0.1 mol/L) of diester in dry methanol. Then an equal vol-
ume of a solution (0.1 mol/L) of diamine in dry methanol
was added. The mixture was left at rt over a period of sev-
eral days (monitored by TLC). Then the solvent was
evaporated and the residue was purified by column
chromatography using a gradient of toluene/chloroform,
chloroform and chloroform/methanol mixtures as eluent.
4.12. (13S, 14S)-13,14-Bis-benzyl-oxymethyl-3,9,12,15,
18,24-hexaoxa-6,12,30-triaza-bicyclo[24.3.1]triaconta-
1(29),26(30),27-triene-5,22-dione 12g
4.12.1. Method B. 8 days, 39%. Yellowish oil.
20
D
½aꢁ = +14.6 (c 1.0, CHCl3); 1H NMR (CDCl3), d:
8.08 (2H, br s –NHCO–), 7.67 (1H, t, J = 10.0), 7.32–
7.21 (12H, m), 4.69 (4H, s), 4.47 (4H, s), 4.09 (4H, s),
3.68–3.51 (22H, m). 13C NMR (CDCl3), d: 169.9,
157.1, 138.3, 137.9 (–Ph), 128.5 (–Ph), 127.8 (–Ph),
121.0, 79.1, 74.3, 73.5, 73.3, 70.8, 70.7, 69.9, 69.6, 38.9.
HR ESIMS m/z calcd for C37H49N3O10 [M+Na]+:
718.3316. Found: 718.3329.
4.9. (7S,8S)-7,8-Bis(benzyloxymethyl)-6,9-dioxa-3,12,18-
triaza-bicyclo[12.3.1]octadeca-1(17),14(18),15-triene-
2,13-dione 12a
4.9.1. Method A: 38.7%; method B. 7 days, 42.0%.
24
D
1
Thick, yellowish oil; ½aꢁ = ꢀ28.8 (c 2.1; CHCl3); H
NMR (500 MHz, CDCl3), d: 8.89 (br m, 2H,
–NHCO–); 8.24 (d, J = 7.8, 2H); 8.03 (t, J = 7.8, 1H);
7.34–7.25 (m, 10H, –Ph); 4.47 (AB/2, J = 12.2, 2H);
4.42 (AB/2, J = 12.2, 2H); 3.90–3.84 (m, 2H); 3.84–
3.80 (m, 2H); 3.76–3.64 (m, 4H); 3.59–3.51 (m, 6H);
13C NMR (50 MHz, CDCl3), d: 162.5; 148.1; 139.4;
137.5; 128.4; 128.0; 127.9; 123.7; 78.7; 73.4; 67.3; 67.0;
38.7; MS (HR ESI) m/z calcd for C29H33N3O6Na
[M+Na]+: 542.2267. Found: 542.2262.
4.13. (13R, 14R)-13,14-Bis(2,2-dimethyl-[1,3]dioxalan-
4-yl)-3,9,12,15,18,24-hexaoxa-6,21,30-triaza-bicyclo-
[24.3.1]triaconta-1(29),26(30),27-triene-5,22-dione 12h
4.13.1. Method B. 7 days, 43%. Yellowish oil.
20
D
½aꢁ = +10.6 (c 1.0, CHCl3); 1H NMR (CDCl3), d:
8.19 (2H, br s –NHCO–), 7.76 (1H, t, J = 9.25), 7.27
(2H, m), 4.74 (4H, s), 4.23–3.91 (10H, m), 3.77–3.72
(4H, m), 3.55 (12H, m), 1.38 (6H, s), 1.31 (6H, s). 13C
NMR (CDCl3), d: 170.1, 157.2, 138.1, 121.1, 108.8,
80.6, 75.7, 74.4, 72.2, 70.9, 70.8, 70.0, 66.7, 38.9, 26.9,
25.5. HR ESIMS m/z calcd for C31H49N3O12
[M+Na]+: 678.3214. Found: 678.3220.
4.10. (10S,11S)-10,11-Bis(benzyloxymethyl)-3,9,12,18-
tetraoxa-6,15,24-triaza-bicyclo[18.3.1]tetracosa-
1(23),20(24),21-triene-5,16-dione 12e
4.10.1. Method A 14.1%; method B. 8 days, 30.0%.
24
D
Thick, yellowish oil. ½aꢁ = +2.2 (c 2.2; CHCl3). 1H
Acknowledgments
NMR (500 MHz, CDCl3), d: 7.71 (t, J = 7.8, 1H);
7.63 (br t, J = ꢂ 5.5, 2H, –NHCO–); 7.35–7.23 (m,
12H); 4.64 (AB/2, J = 11.2, 2H); 4.61 (AB/2, J = 11.2,
2H); 4.40 (AB/2, J = 12.2, 2H); 4.36 (AB/2, J = 12.1,
2H); 4.13 (AB/2, J = 15.6, 2H); 4.08 (AB/2, J = 15.6,
2H); 3.73–3.68 (m, 2H); 3.62–3.48 (m, 10H); 3.44–
3.36 (m, 2H); 13C NMR (50 MHz, CDCl3), d: 169.4;
156.3; 137.8; 137.5; 128.4; 127.7; 127.6; 122.2; 78.3;
74.5; 73.3; 70.8; 70.3; 69.1; 39.7; MS (ESI LR) m/z
calcd for C33H41N3O8Na [M+Na]+: 630.69. Found:
630.3.
This work was supported by the State Committee for
Scientific Research (Project T09A 087 21). The authors
wish to thank the Polish Science Foundation for addi-
tional financial support.
References
1. Achmatowicz, M.; Jurczak, J. Tetrahedron: Asymmetry
2001, 12, 487.
´
2. Zielinski, T.; Achmatowicz, M.; Jurczak, J. Tetrahedron:
Asymmetry 2002, 13, 2053.
4.11. (10R,11R)-10,11-Di-[(4R)-2,2-dimethyl-1,3-di-
oxalane-4-yl]-3,9,12,18-tetraoxa-6,15,24-triaza-bi-
cyclo[18.3.1]tetracosa-1(23),20(24),21-triene-5,16-dione
12f
´
3. Jurczak, J.; Stankiewicz, T.; Sałanski, P.; Kasprzyk, P.;
Lipkowski, P. Tetrahedron 1993, 49, 1478.
´
4. Jurczak, J.; Kasprzyk, P.; Sałanski, P.; Stankiewicz, T.
High Press. Res. 1992, 11, 139.
4.11.1. Method A: 17.6%; method B. 8 days, 26.3%.
5. (a) Gryko, D. T.; Pia˛tek, P.; Pe˛cak, A.; Pałys, M.; Jurczak,
J. Tetrahedron 1998, 54, 7505; (b) Gryko, D. T.; Pe˛cak, A.;
20
D
Colorless solid (foam), mp 51–54 ꢁC; ½aꢁ = +15.8 (c
1
´
Koz´minski, W.; Pia˛tek, P.; Jurczak, J. Supramol. Chem.
2.1; CHCl3); H NMR (500 MHz, CDCl3), d: 7.77 (t,
J = 7.8, 1H); 7.58 (br t, J = ꢂ 5.5, 2H, –NHCO–); 7.33
(d, J = 7.8, 2H); 4.67 (AB/2, J = 11.3, 2H); 4.65 (AB/2,
J = 11.3, 2H); 4.17 (AB/2, J = 15.1, 2H); 4.13 (AB/2,
J = 15.1, 2H); 4.11–4.06 (m, 2H); 3.94 (dd, J = 5.9,
J = 8.3, 2H); 3.83 (dd, J = 5.4, J = 8.3, 2H); 3.80–3.75
(m, 2H); 3.71–3.65 (m, 2H); 3.56–3.52 (m, 2H); 3.52–
3.41 (m, 4H); 1.36 (s, 6H); 1.29 (s, 6H); 13C NMR
(125 MHz, CDCl3), d: 169.4; 156.31; 137.7; 122.5;
2000, 12, 229; (c) Solovꢁev, V. P.; Strakhova, N. N.;
Kazachenko, V. P.; Solotnov, A. F.; Baulin, V. E.;
Raevsky, O. A.; Rudiger, V.; Eblinger, F.; Schneider,
H.-J. Eur. J. Org. Chem. 1998, 1379; (d) Pigot, T.; Duriaez,
M.-C.; Cazaux, L.; Picard, C.; Tisnes, T. J. Chem. Soc.,
´
Perkin Trans. 2 1993, 221; (e) Bako, P.; Fenichel, L.; Toke,
L. Liebigs Ann. Chem. 1990, 1161–1164.
´
6. (a) Nazarenko, A. Y.; Huszthy, P.; Bradshow, J. S.; Lamb,
J. D.; Izatt, R. M. J. Incl. Phenom. 1995, 20, 13; (b)